Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yinhu cold dispersion is a traditional Chinese medicinal formulation used primarily for the treatment of acute upper respiratory tract infections, particularly in children. It is designed to address symptoms associated with "wind-heat" colds, a concept from Traditional Chinese Medicine (TCM) that refers to externally contracted febrile diseases characterized by fever, sore throat, and other related symptoms. The formulation typically contains multiple herbal ingredients known for their antiviral, anti-inflammatory, and antipyretic properties. The mechanism of action is based on TCM principles—dispelling wind and clearing heat—rather than targeting specific molecular pathways as in Western medicine[1][2]. Clinical studies have been conducted to evaluate its effectiveness in real-world medical settings for pediatric populations[1].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Yinhu cold dispersion.